Assenagon Asset Management S.A. Bio Rad Laboratories, Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 41,960 shares of BIO stock, worth $13.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

41,960

Previous 54,332 22.77%

Holding current value

$13.9 Million

Previous $14.8 Million 5.39%

% of portfolio

0.03%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$263.97 - $344.64 $3.27 Million - $4.26 Million	-12,372 Reduced 22.77%	41,960 $14 Million
Q2 2024 Jul 18, 2024	BUY	$268.26 - $339.48 $3.88 Million - $4.91 Million	14,457 Added 36.26%	54,332 $14.8 Million
Q1 2024 Apr 24, 2024	BUY	$304.11 - $351.99 $8.29 Million - $9.6 Million	27,270 Added 216.34%	39,875 $13.8 Million
Q4 2023 Jan 17, 2024	BUY	$269.37 - $365.04 $1.73 Million - $2.35 Million	6,429 Added 104.1%	12,605 $4.07 Million
Q3 2023 Nov 06, 2023	BUY	$350.25 - $422.63 $1.51 Million - $1.82 Million	4,306 Added 230.27%	6,176 $2.21 Million
Q2 2023 Jul 25, 2023	SELL	$359.49 - $486.4 $63,629 - $86,092	-177 Reduced 8.65%	1,870 $708,000
Q1 2023 Apr 18, 2023	SELL	$418.69 - $503.0 $41.3 Million - $49.6 Million	-98,544 Reduced 97.97%	2,047 $980,000
Q4 2022 Jan 12, 2023	BUY	$351.71 - $456.01 $31.3 Million - $40.5 Million	88,853 Added 756.97%	100,591 $42.3 Million
Q2 2022 Jul 27, 2022	SELL	$463.67 - $597.16 $4.65 Million - $5.98 Million	-10,021 Reduced 46.05%	11,738 $5.81 Million
Q1 2022 Apr 25, 2022	BUY	$524.57 - $735.42 $4.09 Million - $5.73 Million	7,791 Added 55.78%	21,759 $12.3 Million
Q4 2021 Feb 01, 2022	SELL	$708.84 - $794.68 $2.43 Million - $2.73 Million	-3,431 Reduced 19.72%	13,968 $10.6 Million
Q3 2021 Oct 19, 2021	BUY	$657.71 - $825.77 $10.7 Million - $13.5 Million	16,302 Added 1486.05%	17,399 $13 Million
Q2 2021 Jul 15, 2021	SELL	$576.64 - $649.04 $16.3 Million - $18.4 Million	-28,273 Reduced 96.26%	1,097 $707,000
Q1 2021 Apr 26, 2021	SELL	$547.01 - $662.35 $37.8 Million - $45.8 Million	-69,186 Reduced 70.2%	29,370 $16.8 Million
Q4 2020 Feb 01, 2021	BUY	$510.68 - $643.45 $48.9 Million - $61.7 Million	95,813 Added 3493.0%	98,556 $57.5 Million
Q3 2020 Oct 07, 2020	SELL	$454.43 - $535.6 $69 Million - $81.3 Million	-151,825 Reduced 98.23%	2,743 $1.41 Million
Q2 2020 Jul 21, 2020	BUY	$334.87 - $493.06 $29.4 Million - $43.3 Million	87,733 Added 131.27%	154,568 $69.8 Million
Q1 2020 Apr 17, 2020	BUY	$320.01 - $409.07 $21.4 Million - $27.3 Million	66,835 New	66,835 $23.4 Million
Q3 2019 Oct 16, 2019	SELL	$304.55 - $345.24 $27.8 Million - $31.5 Million	-91,268 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$286.93 - $312.59 $7.19 Million - $7.84 Million	25,065 Added 37.86%	91,268 $28.5 Million
Q1 2019 Apr 26, 2019	BUY	$224.3 - $317.41 $9.86 Million - $14 Million	43,964 Added 197.69%	66,203 $20.2 Million
Q4 2018 Jan 23, 2019	SELL	$220.1 - $309.0 $21.2 Million - $29.7 Million	-96,258 Reduced 81.23%	22,239 $5.16 Million
Q3 2018 Oct 29, 2018	SELL	$289.28 - $326.15 $2.17 Million - $2.45 Million	-7,498 Reduced 5.95%	118,497 $37.1 Million
Q2 2018 Jul 17, 2018	SELL	$244.1 - $303.88 $725,221 - $902,827	-2,971 Reduced 2.3%	125,995 $36.4 Million
Q1 2018 Apr 30, 2018	BUY	$233.97 - $274.11 $28.3 Million - $33.2 Million	120,999 Added 1518.75%	128,966 $32.3 Million
Q4 2017 Jan 25, 2018	BUY	$216.94 - $271.3 $1.73 Million - $2.16 Million	7,967	7,967 $1.9 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Bio Rad Laboratories, Inc. Transaction History